Brief: Geneuro Will Contribute Its Expertise In Human Endogenous Retroviruses To The €6.8M EU-Funded HERVCOV Precision Medicine Project

Geneuro SA

20/06/2022 17:09

June 20 (Reuters) - Geneuro SA  GNRO.PA :
    * GENEURO WILL CONTRIBUTE ITS EXPERTISE IN HUMAN ENDOGENOUS
RETROVIRUSES TO THE €6.8M EU-FUNDED HERVCOV PRECISION MEDICINE
PROJECT
    * PROJECT FUNDED BY EUROPEAN COMMISSION WITH A GRANT OF EUR
6.8
MILLION THAT INVOLVES RESEARCH CENTERS, COMPANIES AND
ASSOCIATIONS FROM CROATIA, FRANCE, GREECE, ITALY AND SPAIN
    * INITIALLY FOCUSED ON COVID-19 AND POST-COVID SYNDROMES,
THIS
STUDY WILL ALSO PROVIDE INSIGHTS FOR OTHER W-ENV-ASSOCIATED
DISEASES
    * OBJECTIVE OF DELIVERING NOVEL PRECISION-MEDICINE SOLUTIONS
BASED
ON ANALYSIS OF BIOMARKERS, SYMPTOMS AND DISEASE PROGRESSION

Source text for Eikon:  ID:nBw5Nhq6La 
Further company coverage:  GNRO.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))